Wealth Alliance Advisory Group LLC Sells 6,874 Shares of SPDR S&P Biotech ETF (XBI)

Share on StockTwits

Wealth Alliance Advisory Group LLC reduced its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 68.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,145 shares of the exchange traded fund’s stock after selling 6,874 shares during the period. Wealth Alliance Advisory Group LLC’s holdings in SPDR S&P Biotech ETF were worth $226,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FMR LLC lifted its position in shares of SPDR S&P Biotech ETF by 26.1% in the second quarter. FMR LLC now owns 39,992 shares of the exchange traded fund’s stock worth $3,807,000 after purchasing an additional 8,273 shares in the last quarter. Northern Trust Corp raised its position in SPDR S&P Biotech ETF by 56.9% during the second quarter. Northern Trust Corp now owns 4,935 shares of the exchange traded fund’s stock worth $470,000 after acquiring an additional 1,789 shares in the last quarter. Verde Servicos Internacionais S.A. bought a new stake in SPDR S&P Biotech ETF during the third quarter worth $4,127,000. Mitchell Sinkler & Starr PA raised its position in SPDR S&P Biotech ETF by 14.2% during the third quarter. Mitchell Sinkler & Starr PA now owns 6,040 shares of the exchange traded fund’s stock worth $579,000 after acquiring an additional 750 shares in the last quarter. Finally, Cumberland Advisors Inc. raised its position in SPDR S&P Biotech ETF by 31.1% during the third quarter. Cumberland Advisors Inc. now owns 56,640 shares of the exchange traded fund’s stock worth $5,430,000 after acquiring an additional 13,420 shares in the last quarter.

NYSEARCA XBI opened at $82.37 on Monday. SPDR S&P Biotech ETF has a 1 year low of $64.38 and a 1 year high of $101.55.

ILLEGAL ACTIVITY WARNING: “Wealth Alliance Advisory Group LLC Sells 6,874 Shares of SPDR S&P Biotech ETF (XBI)” was posted by Macon Daily and is the property of of Macon Daily. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://macondaily.com/2019/01/28/wealth-alliance-advisory-group-llc-sells-6874-shares-of-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More: Certificate of Deposit (CD)

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply